Lantern Pharma SG&A Expense (Quarterly) Analysis

Lantern Pharma Inc (LTRN)

6.79 +0.31 (+4.78%) USD | NASDAQ | May 09, 16:00

6.79 0.00 (0.00%) After-Hours: 16:25

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	1.304M
September 30, 2023	1.314M
June 30, 2023	1.632M
March 31, 2023	1.733M
December 31, 2022	1.575M
September 30, 2022	1.443M
June 30, 2022	1.406M
March 31, 2022	1.406M
December 31, 2021	1.349M
September 30, 2021	1.184M

Date	Value
June 30, 2021	1.314M
March 31, 2021	1.173M
December 31, 2020	1.548M
September 30, 2020	1.101M
June 30, 2020	0.6764M
March 31, 2020	0.3402M
December 31, 2019	0.4977M
September 30, 2019	0.4413M
June 30, 2019	0.2681M
March 31, 2019	0.2679M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

0.2681M

Minimum

Jun 2019

1.733M

Maximum

Mar 2023

1.142M

Average

1.314M

Median

Sep 2023

SG&A Expense (Quarterly) Benchmarks